​The announcement will be applicable for products seen critical to be marketed, with regards to public health.

The Norwegian Medicines Agency encourage MA Holders of products with the following active substances to apply for a Marketing Authorisation in Norway:

Date of announcementActive substancePharmaceutical formulationStrength
​18.04.2018​nifedipin​immediate release tablets/capsules​10 mg
05.04.2018ampicillinpowder for solution for injection/infusion

500 mg, 1 g and 2 g

The list will be updated as needed

Oppdatert: 18.04.2018

Publisert: 05.04.2018

​Fant du det du lette etter?